Background The purpose of this study was to evaluate outcomes after co
ronary bypass surgery versus coronary angioplasty in 525 patients with
pharmacologically treated diabetes. Diabetic patients constitute a si
gnificant portion of patients considered for coronary revascularizatio
n.;Some studies have shown no difference in long-term outcome when com
paring revascularization mode. Recently, the Bypass Angioplasty Revasc
ularization Investigation reported better survival with bypass surgery
over angioplasty in treated diabetic patients. However, the above stu
dies have been limited by small cohorts of diabetic patients. Methods
and Results By using a single-institution comprehensive database, a re
trospective cohort design was used to study 525 consecutive pharmacolo
gically treated diabetic patients who underwent coronary revasculariza
tion. Patients treated with surgery (n=246) were statistically similar
when comparing age, gender, angina class, and ejection fraction to pa
tients (n=279) treated with angioplasty. Follow-up was complete in 95%
of bypass patients and 99% of angioplasty patients. Mean follow-up wa
s 55.5 months. Complete revascularization was accomplished more often
in the surgery group (79%) than in the angioplasty group (42%; P<.001)
. During a 6-year follow-up, repeat revascularization (8% versus 64%;
P=.001), cardiac events (32% versus 41%; P=.04), and death (30% versus
37%; P=.08) occurred less in the bypass patients than the angioplasty
patients. Multivariable analysis identified age >70 years, ejection f
raction <40%, class IV angina, and incomplete revascularization, but n
ot mode of revascularization, as correlates of late mortality. Conclus
ions For most pharmacologically treated diabetic patients, freedom fro
m death, myocardial infarction, and subsequent revascularization durin
g long-term follow-up is superior with bypass surgery compared with an
gioplasty. This worse outcome was mediated in part by the frequent occ
urrence of incomplete revascularization with angioplasty.